Low testosterone levels predict clinical adverse outcomes in SARS ‐CoV‐2 pneumonia patients
ConclusionOur study demonstrates for the first time that lower baseline levels of TT and cFT levels predict poor prognosis and mortality in SARS ‐CoV‐2 infected men admitted to RICU.
Source: Andrology - Category: Urology & Nephrology Authors: Giulia Rastrelli,
Vincenza Di Stasi,
Francesco Inglese,
Massimiliano Beccaria,
Martina Garuti,
Domenica Di Costanzo,
Fabio Spreafico,
Graziana Francesca Greco,
Giulia Cervi,
Antonietta Pecoriello,
Angela Magini,
Tommaso Todisco,
Sarah Cipriani Tags: ORIGINAL ARTICLE Source Type: research
More News: Coronavirus | COVID-19 | Epidemiology | Hormones | Intensive Care | Low Testosterone | Pandemics | Pneumonia | Respiratory Medicine | SARS | Study | Urology & Nephrology | Women